🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to determine whether, in patients with moderate...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-07
Trial ID
NCT00941031
Evaluate the safety, tolerability and pharmacokinetics of AIN457 when admin...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-03
Trial ID
NCT00809159
This study will assess the efficacy and safety of secukinumab compared to p...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-09-29
Trial ID
NCT02267135
Treatments Being Tested
The purpose of this study was to demonstrate efficacy, including effects on...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-08-30
Trial ID
NCT02771210
Treatments Being Tested
Evaluate the safety, tolerability and pharmacokinetics of AIN457 when admin...
Status
Completed
Location
Novartis Investigative Site
Start Date
2005-12
Trial ID
NCT00669942
This study will assess the safety and efficacy of secukinumab compared to p...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-06
Trial ID
NCT01365455
Treatments Being Tested
Demonstrate superiority of secukinumab over ustekinumab in treatment of mod...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-06-22
Trial ID
NCT02826603
Treatments Being Tested
Evaluate psoriasis severity and its psychosocial impact using a novel Patie...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-05-20
Trial ID
NCT02595970
Treatments Being Tested
The purpose of this study was to provide long term clinical data for the co...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-05-11
Trial ID
NCT01132612
This study is designed to evaluate the proportion of patients achieving rev...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-01
Trial ID
NCT01537432
Treatments Being Tested